Related Experiment Video
Updated: May 11, 2026
11:40
Retroviral Infection of Murine Embryonic Stem Cell Derived Embryoid Body Cells for Analysis of Hematopoietic Differentiation
Published on: October 20, 2014
Puerarin-induced immune hemolytic anemia
Fei Chen1, Shangqin Liu, Jiang Wu
1Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People's Republic of China. chenfeiwh@yahoo.com.cn
International Journal of Hematology
|May 11, 2013
Summary
A rare case of severe drug-induced immune hemolytic anemia (DIIHA) was reported, caused by puerarin, a compound from Radix puerariae. This finding highlights puerarin as a potential cause of severe hemolysis, necessitating cautious use.
Area of Science:
- Hematology
- Immunology
- Pharmacology
Background:
- Drug-induced immune hemolytic anemia (DIIHA) is an uncommon condition.
- Severe hemolysis with rapid hemoglobin decline and hemoglobinuria is exceptionally rare.
Observation:
- A patient presented with severe DIIHA following exposure to puerarin.
- Diagnostic tests confirmed drug-dependent antibodies reacting with RBCs in the presence of puerarin.
Findings:
- Puerarin, a major isoflavonoid from Radix puerariae, was identified as the causative agent.
- This marks a rare association between puerarin and DIIHA.
Implications:
- Puerarin may induce severe hemolytic anemia.
- Caution is advised when using puerarin due to its potential for severe hemolysis.
